Abstract Library

#2889 Transcatheter Arterial Embolization (TAE) of NEN Metastases: Efficacy and Predictors of Response

Introduction: Transcatheter-Arterial embolization (TAE) is an established regional, palliative treatment option for liver metastases in patients (pts) with neuroendocrine neoplasms (NENs).

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Rowland S, Armeni E, Sullivan L, Aristidou I, Gopaul A,

Keywords: NEN, TAE, metastatic liver burden,

#1429 Evaluate the Accuracy of Pathological Diagnosis on Biopsy Specimens from Gastrointestinal Neuroendocrine Tumors

Introduction: Gastrointestinal neuroendocrine neoplasms (GI-NENs) is a highly heterogeneous tumor. The accuracy of pathological diagnosis on the biopsy is crucial for GI-NENs but rarely investigated

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Sun L

Authors: Sun L, Li S, Li J, Lu M, Luo J,

Keywords: Gastrointestinal neuroendocrine neoplasm, morphology, Immunohistochemistry,

#872 Urinary 5-hydroxyindoleacetic Acid In Serotonin-Producing Neuroendocrine Tumors: Correlation with Disease Features and Patients' Survival

Introduction: Urinary 5-hydroxyindoleacetic acid (U-5HIAA) is a useful marker for serotonin-producing neuroendocrine tumors (NETs). Its prognostic role, however, is yet to be fully elucidated.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Bartholomew T, Garcia-Hernandez J, Rossi R, Braude D, Mullan M,

Keywords: U-5HIAA, symptoms, prognosis, survival,

#670 The Relationship Between the Ki-67 Protein and IGF-Related Genes in Gastroenteropancreatic Neuroendocrine Tumor Patients with Normal and Elevated Serum Chromogranin-A

Introduction: GEP-NETs are rare, heterogeneous neoplasms with a distinct biological and clinical behavior. Both IGF-system and Ki-67 indices have been reported as important stimulating factors in carcinogenesis and/or tumor progression. The tumor marker CgA is an independent predictor for survival as well. Currently no data are available about a possible interaction between IGF-system (IGF(-R)s, IRs, BPs) and Ki-67 protein in GEP-NET patients with normal and elevated serum CgA.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: van Adrichem R

Authors: Van Adrichem R, De Herder W, Feelders R, De Martino C, De Krijger R,

Keywords: GEP-NET,

#498 Limitations of Chromogranin A in Clinical Practice

Introduction: Chromogranin-A (CgA) is the most accurate marker for the histological diagnosis of neuroendocrine tumors (NETs). However diagnostic usefulness of circulating CgA is controversial as several conditions, both neoplastic and non-neoplastic, may induce false positive increases of this marker.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Marotta V, Nuzzo V, Ferrara T, Zuccoli A, Del Prete M,

Keywords: Chromogranin A, neuroendocrine tumor, false positive marker,